JD Supra Law

AUGUST 31, 2023

market on March 7, 2025, if approved by FDA. It has been reported that Celltrion has finalized a settlement with Johnson & Johnson (“J&J”) in the United States relating to CT-P43, Celltrion’s ustekinumab biosimilar to J&J’s STELARA®, which would permit Celltrion to launch the product in the U.S. By: Goodwin

Settlement 73

Settlement Reporting Marketing Marketing 73

LexBlog IP

JUNE 13, 2023

. “According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025.” The post Alvotech and Teva Reach Ustekinumab (STELARA) Settlement with J&J appeared first on Big Molecule Watch.

Settlement 52

Settlement Marketing Marketing Licensing 52

LexBlog IP

AUGUST 16, 2023

On August 7, 2023, Formycon AG and Fresenius Kabi announced that they have reached a settlement with Johnson & Johnson (“J&J”) in the United States relating to FYB202, a proposed ustekinumab biosimilar to STELARA®, marketed by J&J. Economic terms of the settlement were not disclosed in the press release.

Settlement 52

Settlement Licensing Confidentiality Marketing 52

LexBlog IP

AUGUST 30, 2023

market on March 7, 2025, if approved by FDA. It has been reported that Celltrion has finalized a settlement with Johnson & Johnson (“J&J”) in the United States relating to CT-P43, Celltrion’s ustekinumab biosimilar to J&J’s STELARA®, which would permit Celltrion to launch the product in the U.S.

Settlement 52

Settlement Confidentiality Marketing Marketing 52

LexBlog IP

FEBRUARY 23, 2024

The settlements cover Canada, the European Economic Area, and Japan, clearing the way for Alvotech to launch AVT04 in those markets, where AVT04 has already received regulatory approval. Alvotech has commercial partners for AVT04 in each of the aforementioned markets. Per the settlement agreement, AVT04 can be marketed in the U.S.,

Settlement 52

Settlement Marketing Marketing Licensing 52

Bio Law Blog

JUNE 21, 2020

settled three Inter Partes Review (IPR) proceedings concerning patents covering Alexion’s blockbuster humanized monoclonal antibody drug Soliris®, with Amgen obtaining a royalty-free license for marketing a biosimilar prior to expiration of the patents at issue. and Alexion Pharmaceuticals Inc. an eculizumab product.

Marketing 52

Marketing Marketing Settlement Patent 52

LexBlog IP

JANUARY 12, 2023

Coherus plans to file an abbreviated Biologics License Application (aBLA) with the FDA later this year and intends to launch the product at EYLEA biosimilar market formation, currently expected to be in 2025.

Marketing 52

Marketing Marketing Licensing Intellectual Property 52

Herbert Smith Freehills

OCTOBER 14, 2021

The global oncology drug market was valued at US$150.3 billion in 2025 at a CAGR of 15.2%, and to grow further to US$482.5 from 2025 to 2030. Precision oncology and immuno-oncology therapies in which Abbisko specialises are expected to account for approximately 90% of the global oncology drug market by 2030. HK?????????06609.HK????????06669.HK??.

Marketing 52

Marketing Marketing Licensing Publishing 52

LexBlog IP

SEPTEMBER 28, 2023

to commercialize several of Abbott’s oncology, women’s health, and respiratory disease biosimilars for emerging markets in Latin America, Southeast Asia, the Middle East, and Africa. According to the press release, the first molecules subject to the agreement are expected to launch as early as 2025.

Marketing 52

Marketing Marketing Contracts Registration 52

IAM Magazine

SEPTEMBER 23, 2021

A new high-level policy calls for growth by a metric that includes not just royalty receipts but also payments to foreign IP owners.

IP 52

IP Licensing Marketing Marketing 52

Herbert Smith Freehills

JANUARY 13, 2022

In 2020, JL Mag ranked first in the world by high-performance REPM production volume with a market share of approximately 14.5%. tonnes in 2025 at a CAGR of 14.7%. "We 2025????????12.91???????????14.7%?. The IPO raised over HK$4.045 billion (approximately US$520 million), and listed on 14 January 2022. tonnes in 2015 to 65,000.0

Marketing 52

Marketing Marketing Publishing Law 52

Herbert Smith Freehills

NOVEMBER 7, 2021

Leading global law firm Herbert Smith Freehills has advised CMBC Securities Company Limited and Guotai Junan Securities (Hong Kong) Limited as joint global coordinators of online marketing solutions provider UJU Holding Limited (01948.HK)'s The online short video marketing market in China increased from RMB30.2 2025????????7043???????????30.7%?.

Advertising 52

Advertising Advertising Marketing Marketing 52

LexBlog IP

NOVEMBER 5, 2023

The licensure and marketing of WEZLANA could affect negotiations with CMS regarding Medicare pricing for STELARA under the Inflation Reduction Act’s Drug Price Negotiation Program. According to a reported statement from Amgen, its settlement agreement with Janssen allows Amgen to sell WEZLANA “no later than January 1, 2025.”

Marketing 40

Marketing Marketing Government Litigation 40

IAM Magazine

SEPTEMBER 23, 2021

A new high-level policy calls for growth by a metric that includes not just royalty receipts but also payments to foreign IP owners.

IP 52

IP Licensing Marketing Marketing 52

Herbert Smith Freehills

DECEMBER 13, 2021

HK), online marketing solutions provider Netjoy Holdings Limited (02131.HK), HK), and online marketing solutions provider UJU Holding Limited (01948.HK). Our proven expertise in advising clients from internet and related sectors adds to our three-decade local capital market capability. "Our billion in 2025 at a CAGR of 40.1%.

Marketing 52

Marketing Marketing Business Technology 52

Technology & Marketing Law Blog

FEBRUARY 29, 2024

WIPIP 2025 will be hosted by the UNLV Law School in Las Vegas. * * * As usual, Prof. This juxtaposition leaves me with a bittersweet memory of WIPIP 2024. We had so much fun together, but it also will be associated with Dan’s death and our community’s loss. My memoriam for Dan.

Fair Use 69

Fair Use Intellectual Property IP Law 69

Velocity of Content

MAY 25, 2023

The program helps Reproduction Rights Organizations (RROs) as they start or develop their operations and may include operational and technical support, training, marketing, educational tools, and more. Last year, IFFRO members elected CCC CEO Tracey Armstrong as President through 2025. “We

Licensing 52

Licensing Journalism Copyright Marketing 52

IIPRD

MARCH 17, 2023

Subsequently, the healthcare sector has gained precedence and command over the market. The global nutraceutical market (including functional food, functional beverages, and dietary supplements) is anticipated to grow by 7.5% (CAGR) between 2022 and 2027, in which the United State market share is considered to be the biggest.

IP 52

IP Intellectual Property Marketing Marketing 52

TorrentFreak

AUGUST 7, 2023

The injunction allows the Premier League to block pirate IPTV services during the 2023/24 season and then the 2024/2025 season after that. Genip.tv, which is linked to geniptv.com, appeared in the MPA’s submission to the USTR’s Notorious Markets report 2021.

Branding 87

Branding Brands Branding Public Domain 87

LexBlog IP

FEBRUARY 1, 2024

In October 2023, Accord settled with Janssen Biotech under confidential terms that would allow Accord to launch its proposed ustekinumab biosimilar no later than May 15, 2025, pending FDA approval.

Confidentiality 52

Confidentiality Reporting Licensing Marketing 52

LexBlog IP

DECEMBER 2, 2021

The incorporation of drones in logistics, security, exploration, agriculture, and transport has led to a projected growth of the drone market to $129.2 billion by 2025.

Privacy 40

Privacy Marketing Marketing Law 40

SpicyIP

MARCH 15, 2024

If the trial spills over to 2025, the defendants will have to bear the cost for that as well. For example, the Swedish Patent and Market Court invalidated two of Nokia’s standard essential patents which were the subject-matter patents in an earlier litigation in Germany. The Court envisaged the completion of trial by the end of 2024.

Patent Infringement 59

Patent Infringement Settlement Patent Licensing 59

LexBlog IP

JANUARY 11, 2022

Subscription marketing is on the rise with some predicting the subscription industry will more than double by 2025. Experts do not forecast this growth will taper off, as it is part of a larger trend of relationship-based marketing. Or perhaps the goal was really to drive app download and loyalty signups.

Marketing 52

Marketing Marketing Contracts Law 52

The IPKat

AUGUST 31, 2023

Open-Source: Requiring code to be openly available may promote transparency and innovation; allowing it to be proprietary may concentrate market power but allow more dependable regulation of harms. Black Box: Some AI models and tools cannot explain why they produce a particular result, which is a challenge to transparency requirements.

Reporting 89

Reporting Technology Intellectual Property Government 89

The IPKat

NOVEMBER 14, 2022

The latter, contrary to what it might appear from its date of adoption (2014), is a regulation that is certainly topical, having started to take effect as of 31 July 2022, with a transitional period that will last until 31 January 2025, but which will see a first and fundamental provision entering into force on 31 January 2023.

IP 76

IP Marketing Marketing Confidentiality 76

LexBlog IP

AUGUST 12, 2021

1, 2025, to Dec. 31, 2025, and requires 15% PCR by weight. The Guides for the Use of Environmental Marketing Claims (Green Guides) are set to be reviewed and revamped in 2022. The Green Guides help marketers ensure their environmental claims are not unfair or deceptive. 1, 2022, to Dec. And by Jan. 1, 2023, through Dec.

Marketing 52

Marketing Marketing Business Advertising 52

LexBlog IP

JANUARY 25, 2024

The licensure and marketing of WEZLANA could affect negotiations with CMS regarding Medicare pricing for STELARA under the Inflation Reduction Act’s Drug Price Negotiation Program. According to a reported statement from Amgen, its settlement agreement with Janssen allows Amgen to sell WEZLANA “no later than January 1, 2025.”

Marketing 52

Marketing Marketing Licensing Litigation 52

The IPKat

JANUARY 19, 2024

The EU Regulation on geographical indication (GI) protection for craft and industrial products was approved by the Council on 9 October 2023 ( IPKat here ), entered into force on 16 November 2023 and will be fully applicable from 1 December 2025. 7 of the Regulation ).

Art 70

Art Registration Law Designs 70

IP Tech Blog

OCTOBER 31, 2023

Based on Ofcom guidance issued yesterday ( [link] ) it appears that the service provider categorisation process will not be completed until the end of next year at the earliest with draft proposals regarding the additional requirements for these larger providers to follow in early 2025.

Law 62

Law Social Media Publishing Technology 62

LexBlog IP

JANUARY 17, 2024

Any reporting company that is created or registered before January 1, 2024, must file a BOI report no later than January 1, 2025. The CTA takes effect on January 1, 2024.

Reporting 52

Reporting Business Editing Ownership 52

LexBlog IP

JUNE 29, 2023

To demonstrate irreparable harm, Biogen pointed to harm in the form of (1) price erosion, (2) lost sales and market share, and (3) reputational harm. For similar reasons, the Court found Biogen’s arguments about loss of market share too speculative. The Court also noted that any harm could be remedied by money damages.

Litigation 52

Litigation Marketing Marketing Patent 52

LexBlog IP

OCTOBER 31, 2023

Based on Ofcom guidance issued yesterday ( [link] ) it appears that the service provider categorisation process will not be completed until the end of next year at the earliest with draft proposals regarding the additional requirements for these larger providers to follow in early 2025.

Law 52

Law Social Media Publishing Intellectual Property 52

LexBlog IP

JANUARY 16, 2023

The European Commission expressed its hope that the provisions of the regulation will enter into force across all EU member states in 2025. These include, among others, the use to take decisions that may be detrimental to a natural person or the use for advertising or marketing.

Intellectual Property 52

Intellectual Property Confidentiality Business Advertising 52

LexBlog IP

AUGUST 29, 2023

Any reporting company that is created or registered before January 1, 2024, must file a report no later than January 1, 2025. Reports will not be accepted prior to January 1, 2024. FinCEN is currently in the process of creating the specific reporting system and additional regulations surrounding the CTA.

Reporting 52

Reporting Ownership Business Editing 52

Technology & Marketing Law Blog

APRIL 28, 2023

If passed, the bill goes into effect July 1, 2024 with the first round of DPIAs due July 1, 2025. Recently, the Senate Judiciary Committee heard the bill for informational purposes. The bill is currently pending approval by both chambers. Enforcement is limited to the MN AG.

Copying 126

Copying Designs Design Blogging 126

Herbert Smith Freehills

SEPTEMBER 10, 2021

A net zero by 2050 target to be included in Australia’s 2025 NDC. The Government has emphasised the Plan’s respect for consumer and business choice while seeking to reduce emissions and help Australian economy capture a share of emerging global markets. . By 2050 to be included in Australia’s 2025 NDC. Commonwealth.

Government 52

Government Technology Business Reporting 52

Herbert Smith Freehills

SEPTEMBER 10, 2021

Under the Paris Agreement, in 2015 Australia first communicated its commitment in its Nationally Determined Contributions (NDCs) of reducing greenhouse gas emissions by 26 to 28% below 2005 levels by 2030 and has indicated that post-2030 targets can be communicated in its next NDCs in 2025. 50-60% by 2025 (on 1990 levels). Queensland.

Government 52

Government Technology Business Reporting 52